|
|
||||||||
J Thorac Cardiovasc Surg 1999;118:1033-1037
© 1999 Mosby, Inc.
SURGERY FOR ACQUIRED CARDIOVASCULAR DISEASE |
From the Departments of Cardiothoracic Surgerya and Intensive Care Medicine,b Royal Perth Hospital, Perth, West Australia.
Address for reprints: Professor Probal Ghosh, Harav Zinger 8, Rishon Le Zion 75255, Israel (E-mail: probalg{at}hotmail.com ).
Background: Low-grade small lymphocytic (B cell) malignancies (encompassing chronic lymphocytic leukemia and some types of non-Hodgkin lymphoma) are diseases of the elderly. Open cardiac procedures are known to have increased risk of postoperative infection and other morbidities in these immunodeficient patients. Outcome of open cardiac procedures in these patients was reviewed retrospectively.
Patients: Thirteen patients (aged 58-82 years, 11 men, 2 women) with these lymphocytopathologic diseases (8 with chronic lymphocytic leukemia and 5 with non-Hodgkin lymphoma) underwent cardiac operations between January 1977 and June 1998. Mean age was 72 ± 2.1 years. Isolated coronary artery bypass grafting was performed in 11 and combined procedures and double valve replacement were performed in 1 each. Preoperatively, 9 patients were in a low-risk clinical stage. Mean preoperative duration of lymphocytopathologic disease was 6.1 ± 1.6 years. Mean preoperative New York Heart Association functional class was 2.8.
Results: There was no operative death. Average stay in the intensive care unit was 41.4 ± 8.6 hours. Postoperative leg and superficial sternal wound infections were encountered in 3 patients. Average postoperative hospital stay was 10.0 ± 1.7 days. During the follow-up up to 72 months, 1 patient underwent a second cardiac operation. There was 1 late death 4 years later. Coronary stenting was done in 1 patient and a cardioverter-defibrillator was implanted in another patient for recurrent angina. Three patients underwent chemotherapy. Cardiac and lymphocytopathologic status remained stable in others.
Conclusions: Acceptable outcome may be anticipated after cardiac operations in patients with low-grade chronic lymphocytic leukemia and non-Hodgkin lymphoma in early stages. However, the possibility of infection and progression of cardiac and lymphocytopathologic status in these patients should call for caution.
This article has been cited by other articles:
![]() |
A. M. Fecher, T. J. Birdas, D. Haybron, P. K. Papasavas, D. Evers, and P. F. Caushaj Cardiac operations in patients with hematologic malignancies Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 537 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. V. Potapov, H. R. Zurbrugg, C. Herzke, S. Srock, H. Riess, R. Sodian, S. Hubler, and R. Hetzer Impact of cardiac surgery using cardiopulmonary bypass on course of chronic lymphatic leukemia: a case-control study Ann. Thorac. Surg., August 1, 2002; 74(2): 384 - 389. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |